- Home
- Companies
- usa new york
- heart attacks
Show results for
Refine by
Heart Attacks Suppliers In Usa New York
5 companies found
based inNew York, NEW YORK (USA)
PMcardio by Powerful Medical is an AI-powered ECG interpretation tool designed to diagnose up to 49 heart conditions, including critical hidden heart attacks. It covers a wide range of diagnoses such as various heart rhythms (e.g., sinus ...
based inAlbany, NEW YORK (USA)
We’re a gas company you can trust. We make it our business to know your business inside and out. Our customer service is the driving force behind Noble Gas Solutions: we’re reliable, responsive, and proactive. Our customers look to us to help them ...
Noble offers a comprehensive line of medical pure and mixed gases for human consumption. Our state of the art fill plant and quality assurance practices ensure accuracy when filling cylinders for our medical customers. Noble offers a variety of ...
based inPort Washington, NEW YORK (USA)
Drive DeVilbiss Healthcare was formed in January 2000 under the name Medical Depot.Inc. Not long after the Company was started, the ownership recognized the opportunity to reflect the spirit of the Company and the quality of life it provides to the ...
Sleep apnea (AP-ne-ah) is a common disorder in which you have one or more pauses in breathing or shallow breaths while you sleep. Breathing pauses can last from a few seconds to minutes. They often occur 5 to 30 times or more an hour. Typically, ...
based inCambridge, MASSACHUSETTS (USA)
At BlueRock, our mission is to create authentic cellular medicines to reverse devastating diseases, with the vision of improving the human condition. Until recently, scientists believed that mature adult cells were permanently locked into their ...
Instead of prescribing a pill to treat tremors in patients with Parkinson’s, we might restore the chemical messengers that were destroyed, addressing tremors at the source. Those who have suffered a heart ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
MPC-25-IC is Mesoblast’s Phase 2 product candidate for the treatment of acute myocardial infarction. This is the first clinical study to evaluate an allogeneic cellular therapy delivered by intracoronary infusion in patients who have suffered ...